Depo-Provera Linked to Increased #HIV Risk in #Africa
The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study published online .
Comments are closed.